MP
Mayur Parekh
Head - Business Development, Portfolio and Strategy
Cipla USA, Inc.
About me
Head of Portfolio, BD and Strategy at Cipla USA. Based in New Jersey, USA Seasoned professional with experience across ANDAs, 505b2s, Biosimilars, Innovative programs and Corporate Venture Investments
Attendee Access type
Attendee
Country
United States
Organization Type
Manufacturer/Innovator
Business Activity
Pharmaceutical Company (generic finished products)Pharmaceutical Company (innovator finished products)
Markets Active In
North America (e.g., USA, Canada)
About me (Individual)
Department
Sales
Job Function
Manager with staff
Purchasing Responsibility
Influence purchase
Geographical areas you plan to expand to:
AfricaSouth Asia (e.g. India, Pakistan, Sri Lanka, e.t.c)
Offering/Interested In
Interested in: Business Type
Contract ManufacturerContract Research OrganisationGeneric APIs producerOut-licensingspecialistPharmaceutical Company (generic finished products)Pharmaceutical Company (innovator finished products)
Interested in: Company Type
Academic/ResearchContract ServiceManufacturer/Innovator
Interested In: Company Certification
GMP
Interested In: Product Certification
FDA
Interested In
Interested In: Products & Service Category
BiopharmaceuticalsFinished Dosage FormsGeneric APIs
Interested In: Biopharmaceuticals
BiosimilarsCHO and cell lines
Interested In: Finished Dosage Formulations
AerosolsCapsulesCreams, Lotions, OintmentsDropsFilmsGel CapsInjectablesParenteralsPowdersSoft tabsSpraysSuppositoriesSuspensionsSyrupsTabletsTransdermal PatchesVolume and electrloyte replacement
Interested In: Generic APIs
Generic AlkaloidsGeneric AlkaloidsGeneric Amino AcidsGeneric AlkaloidsGeneric AntibodiesGeneric AlkaloidsGeneric CytokinesGeneric AlkaloidsGeneric EnzymesGeneric AlkaloidsGeneric Hormones & Synthetic SubstancesGeneric AlkaloidsGeneric Peptides
Content
Company
Cipla USA
Is member of

Cipla Ltd
Exhibitorsis attending
US Pharmaceutical Market Outlook 2021: CDMO Deal Making in a Pandemic and Beyond
Ramesh Subramanian · Aragen Life Sciences
Robert Bloder · Ascendia Pharmaceuticals
COVID-19, the Future of Healthcare and Pandemics
M&A Climate & Current Market Dynamics
Wayne Weiner · Pharmatech Solutions LLC
Ilan Avni · Wavelength Pharmaceuticals